Skip to main content
AAN.com

Abstract

Several sympathomimetic agents have been associated with ischemic and hemorrhagic stroke. Ephedrine, a sympathomimetic drug that has a high potential for abuse and can be readily obtained without a prescription in unrestricted quantities, has rarely been associated with stroke. We report ephedrine-related stroke in three patients. One patient developed a thalamic infarct after ingesting known quantities of ephedrine as street-purchased “speed” for weight loss. Two patients had fatal intracranial hemorrhages after ingesting unknown quantities of ephedrine; one of them had a history of drug abuse, and one lacked a history of ephedrine use or drug abuse. Ephedrine appears to predispose to both ischemic and hemorrhagic stroke. The mechanisms responsible for the different cerebrovascular complications remain to be proven. Restriction of ephedrine availability should be considered.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 43Number 7July 1993
Pages: 1313
PubMed: 8327131

Publication History

Published online: July 1, 1993
Published in print: July 1993

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Askiel Bruno, MD
Neurology Service, Veterans Affairs Medical Center, and the Department of Neurology (Drs. Bruno and Chapin), University of New Mexico School of Medicine, and the Office of the Medical Investigator and Department of Pathology (Dr. Nolte), University of New Mexico School of Medicine, Albuquerque, NM.
Kurt B. Nolte, MD
Neurology Service, Veterans Affairs Medical Center, and the Department of Neurology (Drs. Bruno and Chapin), University of New Mexico School of Medicine, and the Office of the Medical Investigator and Department of Pathology (Dr. Nolte), University of New Mexico School of Medicine, Albuquerque, NM.
John Chapin, MD
Neurology Service, Veterans Affairs Medical Center, and the Department of Neurology (Drs. Bruno and Chapin), University of New Mexico School of Medicine, and the Office of the Medical Investigator and Department of Pathology (Dr. Nolte), University of New Mexico School of Medicine, Albuquerque, NM.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Cerebrospinal Fluid Serotonin level as Biomarker for Neurotoxicity after 3,4-Methylenedioxymethamphetamine (MDMA), Research Journal of Pharmacy and Technology, (3796-3801), (2022).https://doi.org/10.52711/0974-360X.2022.00637
    Crossref
  2. Treatment of “Other” Stroke Etiologies, Stroke, (852-868.e9), (2022).https://doi.org/10.1016/B978-0-323-69424-7.00058-2
    Crossref
  3. Stroke and Substance Abuse, Stroke, (563-572.e15), (2022).https://doi.org/10.1016/B978-0-323-69424-7.00039-9
    Crossref
  4. Effects of Caffeine on Brown Adipose Tissue Thermogenesis and Metabolic Homeostasis: A Review, Frontiers in Neuroscience, 15, (2021).https://doi.org/10.3389/fnins.2021.621356
    Crossref
  5. Ephedrine ameliorates cerebral ischemia injury via inhibiting NOD-like receptor pyrin domain 3 inflammasome activation through the Akt/GSK3β/NRF2 pathway, Human & Experimental Toxicology, 40, 12_suppl, (S540-S552), (2021).https://doi.org/10.1177/09603271211052981
    Crossref
  6. What caused this intracerebral hemorrhage?, Warlow's Stroke, (399-436), (2019).https://doi.org/10.1002/9781118492390.ch8
    Crossref
  7. Plant-Derived Alkaloids, Discovery and Development of Neuroprotective Agents from Natural Products, (237-320), (2018).https://doi.org/10.1016/B978-0-12-809593-5.00006-9
    Crossref
  8. Drugs of abuse from a different toxicological perspective: an updated review of cocaine genotoxicity, Archives of Toxicology, 92, 10, (2987-3006), (2018).https://doi.org/10.1007/s00204-018-2281-1
    Crossref
  9. Toxicity/Substance Abuse, Primer on Cerebrovascular Diseases, (614-622), (2017).https://doi.org/10.1016/B978-0-12-803058-5.00120-X
    Crossref
  10. Performance Enhancing Drug Use in Athletes, Journal of Pharmacy Practice, 9, 5, (386-395), (2016).https://doi.org/10.1177/089719009600900509
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share